SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-016497
Filing Date
2012-03-22
Accepted
2012-03-22 06:30:27
Documents
3
Period of Report
2012-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FORM 8-K v306816_8k.htm 8-K 14487
2 EXHIBIT 99.1 v306816_ex99-1.htm EX-99.1 7889
3 GRAPHIC image_001.jpg GRAPHIC 4210
  Complete submission text file 0001144204-12-016497.txt   29661
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 12707705
SIC: 4731 Arrangement of Transportation of Freight & Cargo